Abstract:Gene expression involves transcription and translation. Despite large datasets and increasingly powerful methods devoted to calculating genetic variants’ effects on transcription, discrepancy between messenger RNA and protein levels hinders the systematic interpretation of the regulatory effects of disease-associated variants. Accurate models of the sequence determinants of translation are needed to close this gap and to interpret disease-associated variants that act on translation. Here we present Translatomer, a multimodal transformer framework that predicts cell-type-specific translation from messenger RNA expression and gene sequence. We train the Translatomer on 33 tissues and cell lines, and show that the inclusion of sequence improves the prediction of ribosome profiling signal, indicating that the Translatomer captures sequence-dependent translational regulatory information. The Translatomer achieves accuracies of 0.72 to 0.80 for the de novo prediction of cell-type-specific ribosome profiling. We develop an in silico mutagenesis tool to estimate mutational effects on translation and demonstrate that variants associated with translation regulation are evolutionarily constrained, both in the human population and across species. In particular, we identify cell-type-specific translational regulatory mechanisms independent of the expression quantitative trait loci for 3,041 non-coding and synonymous variants associated with complex diseases, including Alzheimer’s disease, schizophrenia and congenital heart disease. The Translatomer accurately models the genetic underpinnings of translation, bridging the gap between messenger RNA and protein levels as well as providing valuable mechanistic insights for uninterpreted disease variants. A transformer-based approach called Translatomer is presented, which models cell-type-specific translation from messenger RNA expression and gene sequence, bridging the gap between messenger RNA and protein levels as well as providing a mechanistic insight into the genetic regulation of translation.

Diversity of ribosomes at the level of rRNA variation associated with human health and disease

Improving the Diversity of Captured Full-Length Isoforms Using a Normalized Single-Molecule RNA-sequencing Method

Ribosome heterogeneity in development and disease

Diversity Of 5s Rrna Genes Within Individual Prokaryotic Genomes

Concerted copy number variation balances ribosomal DNA dosage in human and mouse genomes

Transcriptome variation in human tissues revealed by long-read sequencing

Deep Learning Prediction of Ribosome Profiling with Translatomer Reveals Translational Regulation and Interprets Disease Variants

Landscape and Variation of Rna Secondary Structure Across the Human Transcriptome

Structural Diversity of Eukaryotic 18S Rrna and Its Impact on Alignment and Phylogenetic Reconstruction

Epitranscriptomic rRNA fingerprinting reveals tissue-of-origin and tumor-specific signatures

Ribosomal DNA Copy Number Loss and Sequence Variation in Cancer

Comprehensive identification of diverse ribosomal RNA modifications by targeted nanopore direct RNA sequencing and JACUSA2

Decoding regulatory specificity of human ribosomal proteins

Ribosomal RNA 2′O-methylation as a novel layer of inter-tumour heterogeneity in breast cancer

Visualization of chemical modifications in the human 80S ribosome structure

Decoding Ribosome Heterogeneity: A New Horizon in Cancer Therapy

The 3’-untranslated regions of yeast ribosomal protein mRNAs determine paralog incorporation into ribosomes and recruit factors necessary for specialized functions

Thousands of high-quality sequencing samples fail to show meaningful correlation between 5S and 45S ribosomal DNA arrays in humans

Decoding ribosome complexity: role of ribosomal proteins in cancer and disease

Patterns of ribosomal protein expression specify normal and malignant human cells

Novel Insights Of The Gene Translational Dynamic And Complex Revealed By Ribosome Profiling